10 20 30 40 50 60 70 80 1MCB - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER IMMUNOGLOBULIN 25-FEB-93 1MCB
TITLE PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
COMPND MOL_ID: 1; COMPND 2 MOLECULE: IMMUNOGLOBULIN LAMBDA DIMER MCG (LIGHT CHAIN); COMPND 3 CHAIN: A, B; COMPND 4 MOL_ID: 2; COMPND 5 MOLECULE: PEPTIDE N-ACETYL-L-GLN-D-PHE-L-HIS-D-PRO-OH; COMPND 6 CHAIN: P; COMPND 7 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 MOL_ID: 2; SOURCE 6 SYNTHETIC: YES
KEYWDS IMMUNOGLOBULIN
EXPDTA X-RAY DIFFRACTION
AUTHOR A.B.EDMUNDSON,D.L.HARRIS,Z.-C.FAN,L.W.GUDDAT
REVDAT 5 11-SEP-13 1MCB 1 DBREF SEQADV SOURCE VERSN REVDAT 4 25-AUG-09 1MCB 1 SOURCE REVDAT 3 24-FEB-09 1MCB 1 VERSN REVDAT 2 01-APR-03 1MCB 1 JRNL REVDAT 1 31-JAN-94 1MCB 0
JRNL AUTH A.B.EDMUNDSON,D.L.HARRIS,Z.C.FAN,L.W.GUDDAT,B.T.SCHLEY, JRNL AUTH 2 B.L.HANSON,G.TRIBBICK,H.M.GEYSEN JRNL TITL PRINCIPLES AND PITFALLS IN DESIGNING SITE-DIRECTED PEPTIDE JRNL TITL 2 LIGANDS. JRNL REF PROTEINS V. 16 246 1993 JRNL REFN ISSN 0887-3585 JRNL PMID 8346191 JRNL DOI 10.1002/PROT.340160304
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH A.B.EDMUNDSON,K.R.ELY,J.N.HERRON,B.D.CHESON REMARK 1 TITL THE BINDING OF OPIOID PEPTIDES TO THE MCG LIGHT CHAIN DIMER: REMARK 1 TITL 2 FLEXIBLE KEYS AND ADJUSTABLE LOCKS REMARK 1 REF MOL.IMMUNOL. V. 24 915 1987 REMARK 1 REFN ISSN 0161-5890 REMARK 1 REFERENCE 2 REMARK 1 AUTH A.B.EDMUNDSON,K.R.ELY REMARK 1 TITL BINDING OF N-FORMYLATED CHEMOTACTIC PEPTIDES IN CRYSTALS OF REMARK 1 TITL 2 THE MCG LIGHT CHAIN DIMER: SIMILARITIES WITH NEUTROPHIL REMARK 1 TITL 3 RECEPTORS REMARK 1 REF MOL.IMMUNOL. V. 22 463 1985 REMARK 1 REFN ISSN 0161-5890 REMARK 1 REFERENCE 3 REMARK 1 AUTH A.B.EDMUNDSON,K.R.ELY,J.N.HERRON,B.D.CHESON REMARK 1 TITL A SEARCH FOR SITE-FILLING LIGANDS IN THE MCG BENCE-JONES REMARK 1 TITL 2 DIMER: CRYSTAL BINDING STUDIES OF FLUORESCENT COMPOUNDS REMARK 1 REF MOL.IMMUNOL. V. 7 561 1984 REMARK 1 REFN ISSN 0161-5890 REMARK 1 REFERENCE 4 REMARK 1 AUTH A.B.EDMUNDSON,K.R.ELY,R.L.GIRLING,E.E.ABOLA,M.SCHIFFER, REMARK 1 AUTH 2 F.A.WESTHOLM,M.D.FAUSCH,H.F.DEUTSCH REMARK 1 TITL BINDING OF 2,4-DINITROPHENYL COMPOUNDS AND OTHER SMALL REMARK 1 TITL 2 MOLECULES TO A CRYSTALLINE LAMBDAL-TYPE BENCE-JONES DIMER REMARK 1 REF BIOCHEMISTRY V. 13 3816 1974 REMARK 1 REFN ISSN 0006-2960
REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PROLSQ, X-PLOR REMARK 3 AUTHORS : KONNERT,HENDRICKSON,BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.500 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 11140 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3251 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.013 ; 0.025 REMARK 3 ANGLE DISTANCE (A) : 0.029 ; 0.040 REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.027 ; 0.030 REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : 0.011 ; 0.025 REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : 0.122 ; 0.150 REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : 0.184 ; 0.500 REMARK 3 MULTIPLE TORSION (A) : 0.257 ; 0.500 REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : 0.202 ; 0.500 REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : 8.100 ; 8.100 REMARK 3 STAGGERED (DEGREES) : 24.700; 24.700 REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 1MCB COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : PHOTON FACTORY REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : NULL REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : NULL REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 59.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: THIS COMPLEX WAS PREPARED BY REMARK 280 COCRYSTALLIZATION WITH THE PEPTIDE.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 61.96667 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 123.93333 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 123.93333 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 61.96667 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4570 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19070 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -32.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 22 CA - CB - SG ANGL. DEV. = 12.0 DEGREES REMARK 500 GLU A 94 CA - CB - CG ANGL. DEV. = 16.5 DEGREES REMARK 500 LEU A 182 CA - CB - CG ANGL. DEV. = 14.1 DEGREES REMARK 500 CYS B 22 CB - CA - C ANGL. DEV. = 11.8 DEGREES REMARK 500 CYS B 22 CA - CB - SG ANGL. DEV. = 11.9 DEGREES REMARK 500 ASN B 33 N - CA - C ANGL. DEV. = 19.3 DEGREES REMARK 500 LEU B 136 CA - CB - CG ANGL. DEV. = 19.2 DEGREES REMARK 500 DPR P 4 N - CA - C ANGL. DEV. = -16.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 SER A 2 174.54 -56.71 REMARK 500 PRO A 7 128.96 -12.41 REMARK 500 SER A 9 143.54 85.46 REMARK 500 ALA A 10 86.40 175.12 REMARK 500 GLN A 16 -133.91 -77.96 REMARK 500 ASP A 28 -95.50 -127.53 REMARK 500 ASN A 33 40.24 -104.19 REMARK 500 GLN A 39 -109.17 -84.12 REMARK 500 GLN A 40 98.84 82.86 REMARK 500 ALA A 42 114.90 -33.15 REMARK 500 GLU A 52 60.36 39.07 REMARK 500 VAL A 53 -58.93 70.62 REMARK 500 ASP A 62 -5.95 -42.38 REMARK 500 ARG A 63 43.71 -144.82 REMARK 500 SER A 67 114.04 -161.23 REMARK 500 SER A 69 -94.38 -116.54 REMARK 500 LEU A 80 102.29 -52.80 REMARK 500 GLU A 94 71.59 -167.22 REMARK 500 SER A 96 89.49 -21.70 REMARK 500 ASP A 97 27.60 45.74 REMARK 500 PHE A 99 109.72 -172.26 REMARK 500 PRO A 124 116.85 -35.74 REMARK 500 SER A 172 -3.74 -53.09 REMARK 500 ASN A 174 11.44 32.68 REMARK 500 CYS A 215 122.96 -30.78 REMARK 500 SER B 2 -171.59 131.50 REMARK 500 PRO B 8 -77.62 -52.49 REMARK 500 SER B 26 -112.14 46.91 REMARK 500 SER B 27 117.39 -30.98 REMARK 500 ASP B 28 122.30 61.31 REMARK 500 VAL B 29 86.84 38.55 REMARK 500 ALA B 42 95.00 -46.21 REMARK 500 GLU B 52 82.49 52.97 REMARK 500 VAL B 53 -51.62 40.00 REMARK 500 ASP B 62 -27.93 -19.88 REMARK 500 GLU B 83 15.34 -68.20 REMARK 500 ALA B 86 -177.91 -177.16 REMARK 500 GLU B 94 -127.54 -44.59 REMARK 500 SER B 96 -154.18 176.27 REMARK 500 ALA B 131 1.93 -60.82 REMARK 500 ALA B 161 -104.21 -51.70 REMARK 500 ASN B 174 -2.23 63.80 REMARK 500 GLU B 202 -106.31 34.41 REMARK 500 THR B 213 -135.12 -117.69 REMARK 500 GLU B 214 45.96 -162.35 REMARK 500 DHI P 3 73.63 71.38 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 6 PRO A 7 137.36 REMARK 500 DHI P 3 DPR P 4 -111.48 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 DHI P 3 -16.32 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASN B 33 24.2 L L OUTSIDE RANGE REMARK 500 ASN B 98 22.2 L L OUTSIDE RANGE REMARK 500 DHI P 3 35.5 D L WRONG HAND REMARK 500 DPR P 4 -45.5 D D OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE REMARK 800 REMARK 800 SITE_IDENTIFIER: BC3 REMARK 800 EVIDENCE_CODE: AUTHOR REMARK 800 SITE_DESCRIPTION: ANTIGEN COMBINING SITE
REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE LIGHT CHAIN WAS SEQUENCED BY FETT AND DEUTSCH (1974) REMARK 999 BIOCHEMISTRY, 13, 4102-4114.
DBREF 1MCB A 2 216 UNP Q6PIK1 Q6PIK1_HUMAN 21 235 DBREF 1MCB B 2 216 UNP Q6PIK1 Q6PIK1_HUMAN 21 235 DBREF 1MCB P 0 4 PDB 1MCB 1MCB 0 4
SEQADV 1MCB PRO A 1 UNP Q6PIK1 INSERTION SEQADV 1MCB LEU A 14 UNP Q6PIK1 PRO 33 CONFLICT SEQADV 1MCB ALA A 42 UNP Q6PIK1 PRO 61 CONFLICT SEQADV 1MCB VAL A 48 UNP Q6PIK1 LEU 67 CONFLICT SEQADV 1MCB ILE A 49 UNP Q6PIK1 MET 68 CONFLICT SEQADV 1MCB GLU A 94 UNP Q6PIK1 ALA 113 CONFLICT SEQADV 1MCB ASP A 97 UNP Q6PIK1 ASN 116 CONFLICT SEQADV 1MCB PHE A 99 UNP Q6PIK1 TYR 118 CONFLICT SEQADV 1MCB PRO B 1 UNP Q6PIK1 INSERTION SEQADV 1MCB LEU B 14 UNP Q6PIK1 PRO 33 CONFLICT SEQADV 1MCB ALA B 42 UNP Q6PIK1 PRO 61 CONFLICT SEQADV 1MCB VAL B 48 UNP Q6PIK1 LEU 67 CONFLICT SEQADV 1MCB ILE B 49 UNP Q6PIK1 MET 68 CONFLICT SEQADV 1MCB GLU B 94 UNP Q6PIK1 ALA 113 CONFLICT SEQADV 1MCB ASP B 97 UNP Q6PIK1 ASN 116 CONFLICT SEQADV 1MCB PHE B 99 UNP Q6PIK1 TYR 118 CONFLICT
SEQRES 1 A 216 PRO SER ALA LEU THR GLN PRO PRO SER ALA SER GLY SER SEQRES 2 A 216 LEU GLY GLN SER VAL THR ILE SER CYS THR GLY THR SER SEQRES 3 A 216 SER ASP VAL GLY GLY TYR ASN TYR VAL SER TRP TYR GLN SEQRES 4 A 216 GLN HIS ALA GLY LYS ALA PRO LYS VAL ILE ILE TYR GLU SEQRES 5 A 216 VAL ASN LYS ARG PRO SER GLY VAL PRO ASP ARG PHE SER SEQRES 6 A 216 GLY SER LYS SER GLY ASN THR ALA SER LEU THR VAL SER SEQRES 7 A 216 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS SER SEQRES 8 A 216 SER TYR GLU GLY SER ASP ASN PHE VAL PHE GLY THR GLY SEQRES 9 A 216 THR LYS VAL THR VAL LEU GLY GLN PRO LYS ALA ASN PRO SEQRES 10 A 216 THR VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 A 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 A 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP GLY SEQRES 13 A 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR LYS PRO SER SEQRES 14 A 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 A 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 A 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 A 216 THR VAL ALA PRO THR GLU CYS SER SEQRES 1 B 216 PRO SER ALA LEU THR GLN PRO PRO SER ALA SER GLY SER SEQRES 2 B 216 LEU GLY GLN SER VAL THR ILE SER CYS THR GLY THR SER SEQRES 3 B 216 SER ASP VAL GLY GLY TYR ASN TYR VAL SER TRP TYR GLN SEQRES 4 B 216 GLN HIS ALA GLY LYS ALA PRO LYS VAL ILE ILE TYR GLU SEQRES 5 B 216 VAL ASN LYS ARG PRO SER GLY VAL PRO ASP ARG PHE SER SEQRES 6 B 216 GLY SER LYS SER GLY ASN THR ALA SER LEU THR VAL SER SEQRES 7 B 216 GLY LEU GLN ALA GLU ASP GLU ALA ASP TYR TYR CYS SER SEQRES 8 B 216 SER TYR GLU GLY SER ASP ASN PHE VAL PHE GLY THR GLY SEQRES 9 B 216 THR LYS VAL THR VAL LEU GLY GLN PRO LYS ALA ASN PRO SEQRES 10 B 216 THR VAL THR LEU PHE PRO PRO SER SER GLU GLU LEU GLN SEQRES 11 B 216 ALA ASN LYS ALA THR LEU VAL CYS LEU ILE SER ASP PHE SEQRES 12 B 216 TYR PRO GLY ALA VAL THR VAL ALA TRP LYS ALA ASP GLY SEQRES 13 B 216 SER PRO VAL LYS ALA GLY VAL GLU THR THR LYS PRO SER SEQRES 14 B 216 LYS GLN SER ASN ASN LYS TYR ALA ALA SER SER TYR LEU SEQRES 15 B 216 SER LEU THR PRO GLU GLN TRP LYS SER HIS ARG SER TYR SEQRES 16 B 216 SER CYS GLN VAL THR HIS GLU GLY SER THR VAL GLU LYS SEQRES 17 B 216 THR VAL ALA PRO THR GLU CYS SER SEQRES 1 P 5 ACE GLN DPN DHI DPR
HET ACE P 0 3 HET DPN P 2 11 HET DHI P 3 10 HET DPR P 4 8
HETNAM ACE ACETYL GROUP HETNAM DPN D-PHENYLALANINE HETNAM DHI D-HISTIDINE HETNAM DPR D-PROLINE
FORMUL 3 ACE C2 H4 O FORMUL 3 DPN C9 H11 N O2 FORMUL 3 DHI C6 H10 N3 O2 1+ FORMUL 3 DPR C5 H9 N O2
HELIX 1 CH1 GLN A 81 ALA A 82 5 2 HELIX 2 CH2 SER A 125 ASN A 132 1 8 HELIX 3 CH3 THR A 185 HIS A 192 1 8 HELIX 4 CH4 GLN B 81 ALA B 82 5 2 HELIX 5 CH5 SER B 125 ASN B 132 1 8 HELIX 6 CH6 THR B 185 SER B 191 1 7
SHEET 1 1 3 GLY A 15 GLY A 24 0 SHEET 2 1 3 ASN A 71 LEU A 80 -1 O ASN A 71 N GLY A 24 SHEET 3 1 3 ARG A 63 SER A 69 -1 O ARG A 63 N SER A 78 SHEET 1 2 4 VAL A 35 GLN A 40 0 SHEET 2 2 4 LYS A 47 VAL A 53 -1 O LYS A 47 N GLN A 39 SHEET 3 2 4 ALA A 86 GLY A 95 -1 SHEET 4 2 4 ASN A 98 LEU A 110 -1 N ASN A 98 O GLY A 95 SHEET 1 3 4 ALA A 115 PHE A 122 0 SHEET 2 3 4 ALA A 134 TYR A 144 -1 O VAL A 137 N PHE A 122 SHEET 3 3 4 ASN A 174 LEU A 184 -1 N TYR A 176 O PHE A 143 SHEET 4 3 4 GLY A 162 GLN A 171 -1 O GLY A 162 N SER A 183 SHEET 1 4 3 THR A 149 ASP A 155 0 SHEET 2 4 3 SER A 194 HIS A 201 -1 O SER A 194 N ASP A 155 SHEET 3 4 3 SER A 204 VAL A 210 -1 N SER A 204 O HIS A 201 SHEET 1 5 3 GLY B 15 GLY B 24 0 SHEET 2 5 3 ASN B 71 LEU B 80 -1 O ASN B 71 N GLY B 24 SHEET 3 5 3 ARG B 63 SER B 69 -1 O ARG B 63 N SER B 78 SHEET 1 6 4 VAL B 35 GLN B 40 0 SHEET 2 6 4 LYS B 47 VAL B 53 -1 N LYS B 47 O GLN B 39 SHEET 3 6 4 ALA B 86 SER B 92 -1 SHEET 4 6 4 VAL B 100 LEU B 110 -1 N VAL B 100 O SER B 92 SHEET 1 7 4 ALA B 115 PHE B 122 0 SHEET 2 7 4 ALA B 134 TYR B 144 -1 O VAL B 137 N PHE B 122 SHEET 3 7 4 ASN B 174 LEU B 184 -1 N TYR B 176 O PHE B 143 SHEET 4 7 4 GLU B 164 GLN B 171 -1 N GLU B 164 O TYR B 181 SHEET 1 8 3 THR B 149 ASP B 155 0 SHEET 2 8 3 SER B 194 HIS B 201 -1 O SER B 194 N ASP B 155 SHEET 3 8 3 SER B 204 VAL B 210 -1 N SER B 204 O HIS B 201
SSBOND 1 CYS A 22 CYS A 90 1555 1555 2.05 SSBOND 2 CYS A 138 CYS A 197 1555 1555 2.14 SSBOND 3 CYS A 215 CYS B 215 1555 1555 2.03 SSBOND 4 CYS B 22 CYS B 90 1555 1555 2.17 SSBOND 5 CYS B 138 CYS B 197 1555 1555 1.99
LINK C ACE P 0 N GLN P 1 1555 1555 1.33 LINK C GLN P 1 N DPN P 2 1555 1555 1.31 LINK C DPN P 2 N DHI P 3 1555 1555 1.33 LINK C DHI P 3 N DPR P 4 1555 1555 1.38
CISPEP 1 TYR A 144 PRO A 145 0 -10.18 CISPEP 2 TYR B 144 PRO B 145 0 1.39
SITE 1 AC1 14 THR A 23 GLY A 24 THR A 25 SER A 26 SITE 2 AC1 14 SER A 27 ASP A 28 VAL A 29 GLY A 30 SITE 3 AC1 14 GLY A 31 TYR A 32 ASN A 33 TYR A 34 SITE 4 AC1 14 VAL A 35 SER A 36 SITE 1 AC2 6 ILE A 50 TYR A 51 GLU A 52 VAL A 53 SITE 2 AC2 6 ASN A 54 LYS A 55 SITE 1 AC3 10 SER A 91 SER A 92 TYR A 93 GLU A 94 SITE 2 AC3 10 GLY A 95 SER A 96 ASP A 97 ASN A 98 SITE 3 AC3 10 PHE A 99 VAL A 100 SITE 1 BC1 14 THR B 23 GLY B 24 THR B 25 SER B 26 SITE 2 BC1 14 SER B 27 ASP B 28 VAL B 29 GLY B 30 SITE 3 BC1 14 GLY B 31 TYR B 32 ASN B 33 TYR B 34 SITE 4 BC1 14 VAL B 35 SER B 36 SITE 1 BC2 6 ILE B 50 TYR B 51 GLU B 52 VAL B 53 SITE 2 BC2 6 ASN B 54 LYS B 55 SITE 1 BC3 10 SER B 91 SER B 92 TYR B 93 GLU B 94 SITE 2 BC3 10 GLY B 95 SER B 96 ASP B 97 ASN B 98 SITE 3 BC3 10 PHE B 99 VAL B 100
CRYST1 72.300 72.300 185.900 90.00 90.00 120.00 P 31 2 1 12
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.013831 0.007985 0.000000 0.00000
SCALE2 0.000000 0.015971 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005379 0.00000